Bustamante, Jayber C.
HRN: 20-77-97 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2023
CEFUROXIME 750MG (VIAL)
05/30/2023
06/05/2023
IV
330mg
Q8Hrs
AGE With Mod Dehydration
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes